
Closed
Strategic Operating Grant Program
Research funding for arthritis priorities
Record updated
- Funding available
- $ 150,000
- Deadline
- Unspecified
- Location
- Canada
Overview
This program funds research proposals aligned with Arthritis Society Canada’s priorities, with a focus on pain, osteoarthritis, inflammatory arthritis, childhood arthritis, and workplace-related research. The maximum funding is $150,000 per year for up to three years, for a total of $450,000, and the award is non-renewable.
At a glance
Funding available
- Maximum funding
- $150,000
- Conduct research and development activities
- Conduct research or evaluation activities
Eligible candidates
- Location
- Canada
- Eligible Industries
- All industries
- Annual revenue
- All revenue ranges
- Organisation size
- All organization sizes
- Audience
- All groups
- Legal structures
- Non-profit
Non-profit candidates
- Sector of operation
- Research
Receipt of requests is now closed
Get notified about updates to this grant.
Availability timeline
2026
Periods: 1
Eligibility
Who is eligible?
- Eligible Principal Investigators.
- Canadian host institutions.
Eligible geographic areas
- Canada
Activities funded
- Research proposals aligned with Arthritis Society Canada’s priorities.
- Innovative research in pain.
- Innovative research in osteoarthritis.
- Innovative research in inflammatory arthritis.
- Innovative research in childhood arthritis and workplace-related arthritis.
Selection criteria
- Alignment with Arthritis Society Canada’s priorities.
- Focus on the program’s priority research areas.
- Innovation in the proposed research.
- Scientific excellence and rigour.
Processing and Agreement
- Letters of intent are reviewed first.
- Applicants are notified of LOI review results in July.
Additional information
- Applications are tied to Arthritis Society Canada’s research priorities.
- The program is part of the 2020-2027 Strategic Plan: Accelerating Impact - Research Strategy.
- Applicants are notified of LOI review results in July.
Official sources
Frequently Asked Questions about the Strategic Operating Grant Program Program
What is the Strategic Operating Grant Program?
This program funds research proposals aligned with Arthritis Society Canada’s priorities, with a focus on pain, osteoarthritis, inflammatory arthritis, childhood arthritis, and workplace-related research. The maximum funding is $150,000 per year for up to three years, for a total of $450,000, and the award is non-renewable.
How much funding can be received?
Strategic Operating Grant Program Funds up to $150,000 of admissible expenses.
Who is eligible for the Strategic Operating Grant Program program?
To be eligible for the Strategic Operating Grant Program program, you must:
Eligible Principal Investigator required.
Canadian host institution required.
Research must match program priorities.
Who can I contact for more information about the Strategic Operating Grant Program?
You can contact Arthritis Society Canada (ASC).
Where is the Strategic Operating Grant Program available?
The Strategic Operating Grant Program program is available across Canada.
Is the Strategic Operating Grant Program a grant, loan, or tax credit?
Strategic Operating Grant Program is a Grant and Funding
Who are the financial supporters of the Strategic Operating Grant Program?
Strategic Operating Grant Program is funded by Arthritis Society Canada (ASC)
